HighGravityDataUnitedHealth Group — Jul 29, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000731766-25-000228
Showing in the filing
Optum Health earnings from operations
“$3.0 billion to $3.1 billion”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 77
Adjusted Net Earnings per Share (a) for FY2025
“At least $16.00”
Revenue Outlook for FY2025
“$445.5 Billion to $448.0 Billion”
Earnings Outlook (Diluted EPS) for FY2025
“at least $14.65 Per Share”
Return to earnings growth for FY2026
“return to earnings growth”
Total Optum Revenues for FY2025
“$266,000 - $267,500”
Eliminations - Revenue for FY2025
“($164,500) - ($165,000)”
Total UnitedHealth Group - Revenue for FY2025
“$445,500 - $448,000”
Diluted Net Earnings per Share for FY2025
“At least $14.65”
Medical cost ratio for FY2025
“89.25% +/- 25 basis points”
Operating cost ratio for FY2025
“12.75% +/- 25 basis points”
Quarterly dividend rate
“$2.21”
Employer & Individual Revenues for FY2025
“$79,600 - $80,100”
Medicare & Retirement Revenues for FY2025
“$170,200 - $170,700”
Community & State Revenues for FY2025
“$94,200 - $94,700”
Total UnitedHealthcare Revenue for FY2025
“$344,000 - $345,500”
UnitedHealthcare - Operating Earnings for FY2025
“$9,000 - $9,300”
UnitedHealthcare Operating Margin for FY2025
“2.6% - 2.7%”
Commercial Risk - Growth in People Served for FY2025
“(385)”
Commercial Risk - Total People Served for FY2025
“8,460”
Commercial Fee - Growth in People Served for FY2025
“720”
Commercial Fee - Total People Served for FY2025
“21,605”
Total Commercial - Growth in People Served for FY2025
“335”
Total Commercial - Total People Served for FY2025
“30,065”
Medicare Advantage - Growth in People Served for FY2025
“650”
Medicare Advantage - Total People Served for FY2025
“8,495”
Standardized Medicare Supplement - Growth in… for FY2025
“(50)”
Standardized Medicare Supplement - Total Peo… for FY2025
“4,285”
Medicaid - Growth in People Served for FY2025
“200”
Medicaid - Total People Served for FY2025
“7,635”
Total Medical - Growth in People Served for FY2025
“1,135”
Total Medical - Total People Served for FY2025
“50,480”
Stand-Alone Part D Prescription Drug Plans -… for FY2025
“(300)”
Stand-Alone Part D Prescription Drug Plans -… for FY2025
“2,750”
UnitedHealthcare revenues for FY2025
“$344.0 billion to $345.5 billion”
UnitedHealthcare earnings from operations for FY2025
“$9.0 billion to $9.3 billion”
People served with medical benefits, expecte… for FY2025
“up to 1.135 million”
People served with commercial benefits, expe… for FY2025
“up to 335,000”
Growth within self-funded employer-sponsored… for FY2025
“720,000”
People served with commercial insured offeri… for FY2025
“385,000”
Contraction in individual insured offerings for FY2025
“180,000”
Decline in employer-sponsored group products for FY2025
“205,000”
Medical cost trend in Medicare Advantage off… for FY2025
“~7.5%”
Pricing expectation for Medicare Advantage for FY2025
“just over 5%”
Medicare Advantage medical cost trend accele… for FY2026
“nearly 10%”
Optum Health Operating Earnings for FY2025
“$3,000 - $3,100”
Optum Insight Operating Earnings for FY2025
“$3,550 - $3,650”
Optum Rx Operating Earnings for FY2025
“$6,000 - $6,100”
Optum Eliminations Revenues for FY2025
“($5,100)”
Total Optum Operating Margin for FY2025
“4.7% - 4.8%”
Optum Health Fully Accountable Value-Based C… for FY2025
“5 million”
Optum Insight contract revenue backlog for FY2025
“$32.0 billion”
Optum Rx adjusted scripts for FY2025
“1.67 billion”
Optum Health revenues for FY2025
“$101.1 billion to $101.6 billion”
Optum Health earnings from operations for FY2025
“$3.0 billion to $3.1 billion”
Optum Health operating earnings margin for FY2025
“3.0% to 3.1%”
Optum Health patients served under fully acc… for FY2025
“~300,000 to 5 million”
Optum Insight revenues for FY2025
“$19.0 billion to $19.5 billion”
Optum Insight earnings from operations for FY2025
“$3.55 billion to $3.65 billion”
Optum Insight operating earnings margin for FY2025
“18.2% to 19.2%”
Optum Rx revenues for FY2025
“$151.0 billion to $151.5 billion”
Optum Rx earnings from operations for FY2025
“$6.0 billion to $6.1 billion”
Optum Rx operating margin for FY2025
“4.0%”
Revenues - UnitedHealthcare for FY2025
“344,000 - 345,500”
Revenues - Eliminations for FY2025
“(164,500) - (165,000)”
Total consolidated revenue for FY2025
“$445,500 - $448,000”
Earnings from operations - Optum for FY2025
“$12,550 - $12,850”
Total Optum Operating Earnings for FY2025
“$12,550 - $12,850”
Earnings from operations - UnitedHealthcare for FY2025
“9,000 - 9,300”
Total UnitedHealth Group - Operating Earnings for FY2025
“$21,550 - $22,150”
Investment and other income for FY2025
“~$4,400”
Interest expense for FY2025
“~$4,200”
Depreciation and amortization for FY2025
“~$4,300”
Net earnings attributable to UnitedHealth Gr… for FY2025
“At least $13,350”
Diluted weighted-average shares outstanding for FY2025
“912 - 914”
Operating margin for FY2025
“4.8% - 5.0%”
Tax rate for FY2025
“~18.5%”
Cash flows from operations for FY2025
“~$16,000”
Exhibit 99.1 · the passage around this item
… earlier in the release
Patrick Conway, Optum chief executive officer. Optum Health • Full year 2025 revenues for Optum Health are expected to be $101.1 billion to $101.6 billion, a decline of 4% over 2024. Earnings from operations are expected to be $3.0 billion to $3.1 billion. The full year operating earnings margin is estimated at 3.0% to 3.1%. • The number of patients served under fully accountable value-based care models is now expected to increase by ~300,000 to 5 million. The company has intentionally reduced its planned 2025 expansion in new patients served from the initial 650,000 view to 300,000 to better focus on the geographies, practices and clinicians with the most developed capabilities and to strengthen operational execution across the platform. Optum Insight • Full year 2025 Optum Insight revenues are expected to range from $19.0 billion to $19.5 billion compared to $18.8 billion in 2024. Earnings from operations are expected to be $3.55 billion to $3.65 billion. The full year operating earnings margin is estimated at 18.2% to 19.2% and the contract revenue backlog is expected to be $32.0 billion. Optum Rx • Full year 2025 Optum Rx revenues are expected to be $151.0 billion to $151.5 billion compared to $133.2 billion a year ago, with the increase driven by continued strong growth in customers and people served across the company’s integrated pharmacy services offerings. Earnings from operations are expected to be $6.0 billion to $6.1 bi
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.